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The liver is unique in its capacity to regenerate after injury, during which hepatocytes actively divide and
establish cell-cell contacts through cell adhesion complexes. Here, we demonstrate that the loss of a-catenin,
a well-established adhesion component, dramatically disrupts liver regeneration. Using a partial
hepatectomymodel, we show that regenerated livers from a-catenin knockdownmice are grossly larger than
control regenerated livers, with an increase in cell size and proliferation. This increased proliferation
correlated with increased YAP activation, implicating a-catenin in the Hippo/YAP pathway. Additionally,
a-catenin knockdownmice exhibited a phenotype reminiscent of clinical cholestasis, with drastically altered
bile canaliculi, elevated levels of bile components and signs of jaundice and inflammation. The disrupted
regenerative capacity is a result of actin cytoskeletal disorganisation, leading to a loss of apical microvilli,
dilated lumens in the bile canaliculi, and leaky tight junctions. This study illuminates a novel, essential role
for a-catenin in liver regeneration.
L
iver diseases are prevalent worldwide, with American statistics reporting that one in ten people suffer from
some form of liver disease, such as fatty liver, hepatitis C or liver cancer1. Liver disease is also reported to be
the European Union’s fifth leading cause of death, accounting for at least one in six deaths2. Although some
specific therapies are available to treat liver diseases, survival predominantly hinges on the regenerative potential
of the liver. Unlike other organs, the liver is unique in its capacity to recover from injury by regeneration instead of
scar formation3. In light of this, liver regeneration has been studied extensively over the past few decades in an
effort to translate treatment strategies into the clinic. The best-characterised paradigm for investigating liver
regeneration has been through the use of partial hepatectomy in rodents, which results in a liver-specific
regenerative response4. During liver regeneration, different intracellular and extracellular signals are stimulated,
which in turn activate quiescent hepatocytes to re-enter the cell cycle and proliferate, restoring the liver-to-body
mass ratio. The ensuing remodelling of the liver architecture accommodates this increase in cell number and
restores the liver to its normal state prior to regeneration5.
During liver regeneration, newly formed hepatocytes organise into highly polarised cords through the assem-
bly of junctional complexes. Adherens junctions, which are the first critical event in junction formation, initiate
from a cadherin-catenin complex. Classical cadherins are transmembrane glycoproteins that ensure intercellular
adhesion through homophilic interactions and are indirectly connected to the cortical actin cytoskeleton through
a-catenin. Alpha-catenin is a mechanosensor and mechanotransducer with two actin-binding domains6. The
carboxy-terminal domain can either bind directly to actin microfilaments (if a-catenin is subjected to force-
induced trans-conformation)7–9 or to EPLIN (epithelial protein lost in neoplasm)10, which serves as an actin-
bundling filament. The central domain, which needs to be unmasked through acto-myosin force generation at the
C-terminus, becomes accessible for vinculin binding, which, in turn, promotes actin microfilament assembly6.
The adhesive strength is thus maximised when the two sites act in concert11, anchoring the actin filaments
through both EPLIN and vinculin to modulate cytoskeletal changes in response to extracellular signals12.
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Several studies have recently emerged demonstrating new roles for
a-catenin. Rather than just a linker protein, a-catenin is reported to
act as a molecular switch in the control of actin cytoskeletal organi-
sation during adhesion7,13. In addition, ablation of a-catenin in the
mouse epidermis results in defects reminiscent of squamous cell
carcinoma, including hyper-proliferation and irregularities in cell
polarity14. This anti-proliferative role of a-catenin has since been
substantiated with the use of conditional a-catenin knockout mice
targeting the brain15, as well as in studies that have connected a-
catenin with the Hippo pathway16. Also, a role for a-catenin in the
modulation of microtubules has been highlighted17.
Previous work has debated whether proliferation in the liver is
attributed to liver stem cells or adult hepatocytes, but a conclusive
study has elucidated that 99% of new hepatocytes arise from pre-
existing adult hepatocytes18. Hence, examination of the effect of a-
catenin knockdown in existing hepatocytes and how this affects pro-
liferation and the formation of new cell-cell contacts may shed light
on the role of a-catenin in the process of liver regeneration.
Results
To determine the in vivo significance of a-catenin in liver regenera-
tion, a liver-specific knockdown of this gene was accomplished
through a-catenin siRNA packaged into lipid nanoparticles (LNPs)
andmodified to specifically target the liver19–22. Livers, and kidneys as
a control organ, were obtained from mice injected with the siRNA-
LNP on an extended regime (Fig. S1A). These tissues were then
analysed for transcript levels to ensure knockdown and specificity.
A significant reduction in a-catenin expression was observed in the
a-catenin siRNA-injected livers as compared with control siRNA-
injected livers, whereas the control organ (kidney) did not show any
change in transcript levels between the two groups (Fig. 1A).
Similarly, we observed a corresponding reduction in protein levels,
as determined by western blotting and immunohistofluorescence
(Fig. 1B, Fig. S1B–C), the latter showing that a-catenin was uni-
formly silenced throughout the tissue, predominantly in the
hepatocytes.
The liver is made up of functional units consisting of hepatocyte
cords, which form bile canaliculi, and the blood vessels between these
cords. The vascular network forms sinusoids, which are orderly, well-
spaced tubular vessels lining the basolateral membranes of hepato-
cytes. On the apical membrane, bile canaliculi are lined up in a
well-organised network of tubules sealed by tight junctions. The
polarisation of the hepatocyte plasma membrane is critical for the
localisation of transporters, which are essential for hepatocyte func-
tion. To investigate the role of a-catenin in the structural formation
and maintenance of the liver, a well-established liver regeneration
model (partial hepatectomy) was chosen for its reproducibility and
efficacy4 (Fig. S1A). Under surgical conditions, two-thirds of the liver
was removed, and the regenerated lobes were harvested seven days
later; this time period is sufficient to allow for more than 70% regen-
eration of the liver mass4. Interestingly, we found that a-catenin
knockdown livers exhibited a vastly perturbed phenotype. There
was a disruption of hepatic cords associated with hepatocellular
hypertrophy and hyperplasia in knockdown mice. The hypertrophic
hepatocytes were enlarged with granular or ‘‘ground glass’’ deep
eosinophilic cytoplasms and enlarged nuclei, predominantly
observed in periportal and mid-zonal areas and, to a lesser extent,
around the central vein (Fig. S2). The sinusoids in knockdown livers
were highly tortuous, disorganised and unevenly spaced. The bile
canalicular network, as visualized by ZO-1 immunolabeling, was also
grossly disorganised, with the normally branched network replaced
with misshapen, disconnected structures with enlarged lumens
(Fig. 1C). In order to ascertain that this disorganization was attrib-
uted to a-catenin knockdown in hepatocytes specifically, we silenced
a-catenin in AML12 cells, a mouse hepatocyte cell line known to
exhibit typical hepatocyte features such as peroxisomes and bile
canalicular-like structures. The knockdown of a-catenin elicited a
disruption in ZO-1 labelling reminiscent of that observed in vivo
(Fig. S3A). Similarly, when a-catenin was silenced in isolated primary
hepatocytes, the bile canaliculi exhibited enlarged lumens, as
observed in vivo (Fig. S3B). We also noted hepatomegaly in the
knockdown livers, with enlargements at both the physical and cel-
lular levels and a 60% increase in the liver-to-body weight ratio
(Fig. 1D). Upon closer inspection, we saw that the knockdown livers
possessed a greater percentage of larger hepatocytes (Fig. 1E). Further
analysis of cell size showed a great variation in cell size in the knock-
down livers, with a significantly greater percentage of cells that were
smaller and larger than the median size (100–250 mm), which led to a
corresponding decrease in the median size as compared with the
controls (Fig. 1F). This non-uniformity in hepatocyte cell size reflects
a general disorganisation of the liver, as hepatocytes are usually uni-
form in size so as to maintain the ordered arrangement of vessels
along the hepatocyte cords. At the morphological level, our results
indicate that the knockdown of a-catenin impaired the mechanisms
of liver regeneration to induce a severely disorganised liver structure.
To further investigate the effect of this disorganisation on liver
metabolism, several liver enzymes were measured from blood sam-
ples obtained from these mice. Interestingly, a-catenin knockdown
mice exhibited a significant increase in alkaline phosphatase (ALP)
and total bilirubin (TBIL) levels. Clinically, these changes are indi-
cative of a disruption in bile flow, which manifests as a medical
condition known as cholestasis in humans (Fig. 2A). Amylase
(AMY) levels were also elevated, which may occur following the
blockage of bile transport (Fig. 2A). A subset of mice also exhibited
signs of jaundice, with yellow skin pigmentation, which is consistent
with the elevated bilirubin levels (data not shown). Since a disruption
in bile flow would imply an accumulation of bile acids in the blood
circulation, we next evaluated the total bile acid (TBA) levels in the
plasma. As expected, we found a 10-fold increase in serumTBA levels
in a-catenin knockdown mice as compared with control mice, con-
sistent with a cholestasis-like phenotype (Fig. 2B). In addition,
because bile is usually secreted into the stomach for the reabsorption
of lipids, a decrease in lipid content would be expected if there were
an obstruction in bile flow. Indeed, the level of high density lipopro-
tein (HDL) was significantly lower in the a-catenin knockdownmice
(Fig. 2C). Finally, a haematological analysis was performed to assess
for signs of inflammation. The total white blood cell count, including
all cellular subtypes (neutrophil, lymphocytes, monocytes and eosi-
nophils), was elevated in the knockdown mice, consistent with an
inflammatory response (Fig. 2D).
In order to determine if the effect of a-catenin knockdown was
pertinent to the regenerative process, a-catenin expression was
silenced in the absence of partial hepatectomy. A significantly more
modest phenotype was observed. The bile canaliculi exhibited a par-
tial loss of its branched structure with slightly enlarged lumens (Fig.
S4A). Alkaline phosphatase and amylase levels were significantly
elevated in a-catenin knockdown mice (Fig. S4B–C), but we mea-
sured no significant change in total bilirubin levels (Fig. S4D). In
addition, there was no significant increase in liver mass in a-catenin
knockdown mice (Fig. S4E).
Next, we sought to understand how the loss of a-catenin induced
these defects. The observed increase in liver size could be due to an
increase in hepatocyte cell size or an increase in cell number. Thus,
we generated a liver simulation model to calculate the hypothetical
increase in liver size that could be caused solely by an increase in cell
size. This analysis indicated that the observed increase in cell size
could account for only a 1.3% increase in livermass (Fig. S5). Thus, to
ascertain if the increase in liver size was instead due to proliferation,
regenerated liver sections were immunolabelled with the proliferat-
ive marker Ki67. Knockdown liver sections showed a much greater
extent of positive Ki67 staining as compared with control sections.
Quantification of the percentage of Ki67-positive cells showed a 6-
www.nature.com/scientificreports
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Figure 1 | Specific knockdown of a-catenin in liver induces major alterations to the hepatic functional unit. (A) a-catenin siRNA-nanolipid particle
(LNP)-injected mice exhibited a specific knockdown in a-catenin transcript levels (n56 for each group) in liver but not in kidney (n54 for each group).
(B) a-catenin protein levels in liver showed a corresponding decrease (n56 for each group). Gel image shown is cropped for concise presentation.
(C) Regenerated liver tissues were immunolabelled with antibodies directed against collagen IV (red; 103 and 203) and zona occludens (ZO)-1 (green;
403 magnification). Sinusoids labelled with collagen IV were tortuous and disorganised in a-catenin siRNA-treated livers. Bile canaliculi
immunolabelled with ZO-1 were arranged in an organised network of tubular structures, whereas a disruption in this network was observed in a-catenin
siRNA-injected livers. The lumens of the BC were also enlarged. (D) Upon harvesting, the livers were dissected and weighed. The a-catenin siRNA-
injected livers were 50%bigger than the control livers. (E) Immunolabelling of cell membranes of liver sections withN-cadherin (red; 203magnification)
revealed that some cells in a-catenin siRNA-injected livers were significantly larger. (F) A statistical analysis of the cell size profile of the experimental
livers was performed. Top: The probability distribution graph of the cells was computed and shown. Bottom: The difference between control and a-
catenin siRNA cell populations was computed and is represented by the percentage change between the siRNA and control populations. This shows that
a-catenin siRNA-injected livers were more highly enriched in the smaller and larger cell fractions as compared with control livers (Control: n58, a-cat:
n511). Scale bars, 50 mm.
www.nature.com/scientificreports
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Figure 2 | Blood chemistry of a-catenin-knockdownmice is indicative of cholestasis in vivo. Blood chemistry analysis was performed on blood samples
taken from mice at the time of liver harvesting, and several markers linked to liver function were measured. (A) Alkaline phosphatase (ALP) levels were
significantly higher in the a-catenin siRNA-injected group. High ALP levels are clinically linked to bile canaliculi malfunction. Total bilirubin (TBIL)
content was also elevated in the siRNA-injected group as compared with the control, which suggests a dysfunction in bile production and flow. Amylase
(AMY) levels were also significantly higher in the a-catenin-injected group, which is clinically linked to disrupted bile flow (Control: n517, a-cat: n521).
(B) Total bile acid (TBA) levels were also elevated in the a-catenin-injected group, indicating that there is a high build-up of TBA in the blood. (C) High-
density lipoprotein (HDL) levels were significantly decreased in a-catenin-injected group, corresponding to a blockage in bile transport (con: n59,
a-cat: n510). (D) siRNA-injected mice exhibited a significantly higher total white blood cells (WBC), suggesting inflammation. Furthermore, the
different subsets within the white blood cell population were all significantly higher, including neutrophils (NE) andmonocytes (MO), lymphocytes (LY)
and eosinophils (EO). K/ml: Thousands per microliter of blood (con: n517, siRNA: n521).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 6835 | DOI: 10.1038/srep06835 4
fold increase in Ki67-labelled cells in a-catenin knockdown livers as
compared with the controls (13.37% versus 2.1%, respectively)
(Fig. 3A).
Previous reports have linked increased proliferation in the liver to
the Hippo-YAP pathway. In addition, a-catenin has been identified
as a physical interactor of Yap1, a prominent player in the Hippo
pathway16. To explore this possible link, we performed western blot-
ting to determine any change in YAP phosphorylation, a post-trans-
lational modification that interferes with its nuclear localisation.
Interestingly, a-catenin knockdown resulted in a consistent decrease
in the percentage of phosphorylated YAP (as a function of total
YAP), hence supporting the involvement of this pathway in cell
proliferation (Fig. 3B). Given that phosphorylated/activated YAP
translocates to the nucleus to activate downstream transcriptional
targets, we next sought to determine the percentage of YAP nuclear
translocation by quantifying the percentage of YAP-positive nuclei.
Alpha-catenin knockdown livers exhibited almost a doubling of the
percentage of YAP-positive nuclei, verifying that YAP signalling is
indeed potentiated by the loss of a-catenin (Fig. 3C). The decrease in
percentage of phosphorylated YAP to total YAP is a decrease from
52% to 32%, which is approximately a 40% decrease. The increase in
percentage of YAP-positive nuclei is from 37% to 78%, which is a
little over a two-fold increase. Considering that these two results were
obtained from different types of assays, we think that the results are
strikingly consistent, taking in account an expected level of disparity
due to the different nature of the assays. In addition, we examined the
expression level of connective tissue growth factor (CTGF), an
important YAP downstream target (Fig. 3D). We found that
CTGF was significantly up-regulated in a-catenin knockdown liver,
substantiating the involvement of the YAP signalling pathway.
In clinical cases of cholestasis, the dysfunction in bile flow
observed in patients has been linked to either a change in the express-
ion levels of crucial bile transporters or to cytoskeletal changes,
which, in turn, lead to leaky tight junctions that fail to adequately
seal the bile canaliculi23. Although the disruption in the bile canali-
cular network in this case points to the latter theory, we still exam-
ined the expression of four different transporters implicated in
cholestasis to rule out the possibility24: Multidrug resistance-assoc-
iated protein-2 (Mrp2), Mrp3, multidrug resistance gene-1 (Mdr1,
otherwise known as P-glycoprotein multidrug transporter (Pgp) or
ABCB1), and Mdr2. As expected, there were no significant changes
in the expression levels of these proteins, suggesting that the disrup-
tion of bile flow did not involve changes in the bile transporter
proteins (Fig. 4A). Most human and animal cholestatic liver disor-
ders are associated with changes in the hepatocyte cytoskeleton,
which includes an accumulation of disorganised actin filament bun-
dles in the pericanalicular domain. This, in turn, results in the loss of
apical microvilli and diminished contractility of the canalicular
membrane, which may contribute to the leakiness of tight junc-
tions24. Alpha-catenin is known to associate with cortical actin fila-
ments; therefore, we investigated the localisation of actin filaments
using phalloidin staining. In the control livers, actin bundles outlined
the periphery of the cell membranes in an organised, pericanalicular
pattern, whereas, in knockdown livers, the actin filaments were
grossly distorted, misshapen and did not continuously line the cell
cortex (Fig. 4B).
We hypothesised that, if this disorganisation of actin filaments did
indeed perturb the microvilli and contractibility of the canalicular
membrane, the morphology of the bile canaliculi would be altered.
Strikingly, electron microscopy showed highly dilated bile canalicu-
lar lumens in a-catenin knockdown livers, suggesting a diminished
contractibility of the liver specimens. In addition, there was a severe
reduction in the proportion of microvilli as compared with that
observed in control livers (Fig. 4C). In control livers, tight junctions
were marked by a distinct darker region comprising two apposed
membrane bilayers. In contrast, in a-catenin knockdown livers, a
space was observed between the plasma membranes on either side
of the bile canaliculi, suggesting compromised integrity of the tight
junctions (Fig. 4D). Hence, the loss of a-catenin resulted in the dis-
organisation of the actin filaments, leading to the loss of apicalmicro-
villi and dilated bile canaliculi with leaky tight junctions, which, in
turn, resulted in a disruption to bile flow.
Finally, it was of interest to investigate the timeline of the defects
brought about by the loss of a-catenin. Hence, a-catenin knockdown
livers and blood samples were examined at different time points after
partial hepatectomy: 1, 2, 4, and 6 days after surgery. The TBA and
TBIL levels in the bloodstream of these mice were significantly ele-
vated as early as day 1 after surgery, peaking at day 4 (Fig. 5A–B).
Correlatively, the structure of the bile canaliculi was disorganised
from day 1 after surgery, with observations of enlarged lumens that
persisted until the day-6 time point (Fig. 5C). The liver-to-body
weight ratio gradually increased in a-catenin knockdown mice from
day 1, albeit with a significant up-regulation observed only from day
2 after surgery (Fig. 5D). In addition, nuclear immunolabeling of
YAP was significantly higher in a-catenin knockdown livers from
as early as day 1 and persisted through until day 6 (Fig. 5E).
Additionally, CTGF expression was significantly up-regulated
between days 1 and 2, which corresponds to the peak of hepatocyte
proliferation (Fig. 5F). In all, these results suggest that the presence of
a-catenin is crucial throughout the entire process of liver regenera-
tion and that the loss of a-catenin causes chronic and persistent
defects in the regenerative process.
Discussion
Alpha-catenin has recently been uncovered to exert other functions
aside from its role as a linker between cadherin and actin microfila-
ments13,25. In this study, we have unravelled a plethora of effects in
liver regeneration attributed to the loss of a-catenin. Regenerated a-
catenin knockdown livers were significantly larger than control
regenerated livers, with the enlargement linked to an increase in
hepatocyte proliferation. Similar increases in cell proliferation in
response to the loss of a-catenin have been observed previously in
other systems. Ablation of a-catenin in the mouse epidermis results
in defects resembling the phenotype of squamous cell carcinoma,
including hyperproliferation and altered cell polarity14. The hyper-
proliferation was found to be independent of cell adhesion and Wnt
signalling, but connected to the Ras/MAPK pathway. In addition, a
conditional knockout of a-catenin in the brain also causes hyperpro-
liferation, which was attributed to the possible involvement of a-
catenin in the Hedgehog pathway15. A previous study has also iden-
tified the involvement of b-catenin/Wnt signalling during the early
stages of normal liver regeneration. Beta-catenin was shown to have
an increased nuclear localisation as a result of its decreased degra-
dation, which was thought to contribute to the increase in prolifera-
tion observed during regeneration26. In addition to these pathways,
a-catenin has also been shown to negatively regulate Yap116, with the
silencing of a-catenin resulting inthe relocalisation of YAP to the
nucleus where it interacts with TEAD transcription factors to induce
proliferation. More importantly, an overexpression of YAP drastic-
ally increases liver mass in mice27, which is similar to our findings
here. One noteworthy point to bring up is that our,6-fold increase
in the percentage of Ki67-positive cells correlates with a 50% increase
in liver mass, which is in line with their study that reports an almost
4-fold increase in percentage of Ki67-positive cells correlating with a
30% increase in liver mass, hence strengthening our data. Our results
also point to a-catenin as a negative regulator of proliferation
through distinct signalling pathways. It is highly plausible that the
micro-environment dictates the degree of interaction between a-
catenin and the different pathways. In our study, we found the
increase in proliferation to be connected to the Hippo-YAP pathway.
The loss of a-catenin in regenerated livers was accompanied by YAP
activation, an increase in its nuclear translocation, as well as an
www.nature.com/scientificreports
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Figure 3 | Increase in liver size is caused by an increase in hepatocyte proliferation via the activation of YAP. (A) Nuclei of cells from liver sections were
immunolabelled with anti-Ki67 antibody (green) and DAPI (blue). Left: Representative images of control and a-catenin knockdown liver sections. Scale
bars, 50 mm. Right graph: The percentage of Ki67-positive cells out of all nuclei-positive cells was then calculated for a-catenin knockdown and control
livers. a-catenin knockdown livers exhibited a much greater level of proliferation (%) as compared with the control livers (13.37% versus 2.1%,
respectively). (B) Liver lysates were blotted for phosphorylated (p) YAP and total (t) YAP, and the ratio of phosphorylated YAP to total YAP (as a
percentage) was significantly lower in the a-catenin knockdown livers (n59 for each group). Gel images shown are cropped and representative of gels run
under the same experimental conditions. (C) Nuclei of cells from liver sections were immunolabelled with anti-YAP antibody (brown). Top:
Representative images of control and a-catenin knockdown liver sections. Scale bars, 50 mm. Left bottom graph: The percentage of YAP-positive (1ve)
nuclei was calculated for a-catenin knockdown and control livers (n57 for each group). (D) Connective tissue growth factor (CTGF), an important
downstream transcriptional target of YAP, was assessed for gene expression levels. CTGF was found to be substantially up-regulated in alpha-catenin
knockdown liver (n57 for control group, n510 for alpha-catenin group).
www.nature.com/scientificreports
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Figure 4 | Bile canaliculi (BC) disruption caused by actin cytoskeleton disorganisation results in a loss of microvilli and dilated BC lumens. (A) The
real-time expression of four important bile transporter proteins—Multidrug resistance-associated protein-2 (Mrp2),Mrp3, multidrug resistance gene-1
(Mdr1, otherwise known as P-glycoprotein multidrug transporter (Pgp) or ABCB1), and Mdr2—was measured in a-catenin knockdown livers and
compared with control livers. No significant change was observed for any of the proteins. (B) Liver sections were immunolabelled with phalloidin to stain
for F-actin (green) and with DAPI (blue) and visualized by confocal microscopy. Representative staining shows that actin microfilaments are arranged
along the cell periphery in an organised pericanalicular pattern in control livers, but are grossly distorted and misshapen in a-catenin knockdown livers.
Scale bar, 20 mm. (C-D)Representative images from electronmicroscopy performed ona-catenin knockdown and control livers. (C)Control BC consists
of lumens filled with microvilli, as shown. Strikingly, the BC in a-catenin knockdownmice possess increased dilation in the lumens, with a severe paucity
of microvilli. (D) A closer look at the tight junctions that seal the BC is shown in themagnified insets (bottom row). In control livers, tight junctions were
marked by a fusion of twomembranes into a characteristic darker single membrane. In contrast, there was an absence of fusion of the membranes on the
sides of the BC in a-catenin knockdown livers, with tight junction regions exhibiting two separated plasma membranes. Scale bars, 0.2 mm.
www.nature.com/scientificreports
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Figure 5 | a-catenin is required throughout the entire timeline of liver regeneration. a-catenin siRNA-nanolipid particle (LNP)-injected mice were
subjected to surgery and assessed at 1, 2, 4, 6 days after surgery for blood and liver analyses. (A) a-catenin siRNA-LNP-injectedmice exhibited a significant
increase in total bile acids from day 1 with a peak at day 4. (B) Total bilirubin levels (TBIL) showed a corresponding increase from day 1, again peaking at
day 4. (C) ZO-1 staining (green) for bile canaliculi structure was disrupted in a-catenin siRNA-LNP injected mice as early as day 1 after surgery and
persisted until day 6. (D) The total liver-to-body weight ratio was significantly increased only from day 2 (n53 for each time point except day 6; n52 for
control group). All paired groups had significant p-values except day 6 (not significant). Scale bars, 20 mm. (E) Nuclei of cells from liver sections were
immunolabelled with anti-YAP antibody (brown). The percentage of YAP-positive (1ve) nuclei was then calculated for a-catenin knockdown and
control livers at each time point. Significant differences were measured at each time-point (p,0.05). (F) Gene expression of connective tissue growth
factor (CTGF). CTGF was substantially up-regulated from day 2 onwards. Significant differences were measured at each time-point (p,0.05).
www.nature.com/scientificreports
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increase in expression of CTGF, a direct YAP downstream target
important for cell growth28. Notably, the increase in YAP nuclear
translocation and CTGF expression occurred within the first two
days of regeneration, corresponding to the peak proliferative period
of hepatocytes. Hence, in accordance with previous studies, our
results indicate that the loss of a-catenin results in an increase in
the activation of YAP, which in turn, causes an increase in
proliferation.
The liver-to-body mass ratio is consistently restored after the liver
has regenerated3,5. Our observation of a greater liver-to-body mass
ratio in a-catenin knockdown liversmay imply that a-catenin plays a
role in this master regulation. Hepatomegaly is present in many
diseases, such as cirrhosis, fatty liver disease and in the obstruction
of bile flow. Hence, the hepatomegaly observed in this case is possibly
indicative of liver damage or malfunction. Previously, the activation
or dysregulation of b-catenin has been shown to up-regulate the
mTOR pathway in colon and ovarian tumours29,30. In our case, how-
ever, the increase in cell size was not attributed to an up-regulation of
themTOR pathway, as we did not observe any change in phosphory-
lated S6 kinase levels (data not shown). We also did not observe a
significant change in b-catenin nuclear translocation in response to
a-catenin knockdown, nor did we observe any significant increase in
polyploidy, which could have contributed to cell hypertrophy (data
not shown). Hence, the increase in cell size in our study is more likely
due to dysregulation of the actin microfilaments, which could con-
tribute to the change in cell size, perhaps through osmotic pressure
changes31.
Normal bile formation and flow are important for proper home-
ostasis. The production of bile is crucial for the digestion of fat, the
absorption of lipids and fat-soluble vitamins, and the excretion of
bilirubin, a by-product of recycled red blood cells.We found elevated
levels of various plasma components, including TBIL, TBA, ALP and
AMY, in our a-catenin knockdownmice, indicative of a defect in bile
flow. Clinically, elevated TBA and TBIL levels are bona fide indica-
tors of cholestasis, as is jaundice, which we observed in a subset of our
a-catenin knockdown mice. Cholestasis occurs in various patholo-
gies, such as primary liver cirrhosis, alcoholic liver disease, bile duct
tumours and hepatitis, and is characterised by a blockage of bile flow
and therefore frequently associated with hepatomegaly, inflam-
mation, and decreased lipid levels. The phenotype observed in these
a-catenin knockdown regenerated livers is characteristic of clinical
cholestasis, with observations of disorganised bile canaliculi, hepato-
megaly, elevated liver enzymes, bile salts and inflammation. Under
conditions of cholestasis, a decrease in plasma HDL cholesterol is
usually accompanied by an increase in plasma cholesterol; however,
only HDL was affected in our a-catenin knockdown mice. This
decrease in HDL likely derives from the increase in TBA, which,
itself, activates the inhibitory FXR element on the promoter region
of HDL32. FXR increases cholesterol ester transfer protein (CETP)
activity, which transfers cholesterol from HDL to non-HDL part-
icles33. Although there was no significant increase in total cholesterol,
there was an increase in non-HDL particles, albeit an insignificant
one.
The sinusoidal and bile canalicular networks of the regenerated a-
catenin knockdown livers showed disorganised actin bundles at the
pericanalicular domain, with tortuous and disorderly sinusoids.
Also, the bile canaliculi exhibited dilated lumens with a loss ofmicro-
villi and compromised tight junction integrity. One hypothesis is that
the loss of a-catenin is equivalent to the lack of a molecular switch to
control the actin filaments13, resulting in actin cytoskeleton disrup-
tion and the ensuing perturbations to the bile canaliculi. Alpha-cate-
nin is a central regulator of actin polymerisation in adherens
junctions and acts as a mechanosensor and transducer in response
to forces locally applied to this plasma membrane subdomain. In
addition, zona occludens-1 (ZO-1), principally localised at the tight
junction cytoplasmic domain, can also interact with a-catenin to
locally control actin polymerisation34. Hence, it is not surprising that
the loss of a-catenin resulted in the disorganisation of ZO-1. Any
disruption in actin microfilament dynamics will have an impact on
the stability of tight junctions, which, themselves, critically depend
on the integrity of adherens junctions35. The lack of full-length a-
catenin considerably affects the strength of the adhesion and pre-
vents the expansion of the contact area in cell doublets36. Following
these cytoskeletal changes, bile canaliculi in regenerating livers could
develop abnormally dilated lumens with a loss ofmicrovilli and leaky
tight junctions. Notably, these cytoskeletal changes have been impli-
cated in many human and animal cholestastic disorders37, and have
been shown to cause a loss of apical microvilli and diminished con-
tractibility of the bile canaliculi38. Moreover, an experimental induc-
tion of cholestasis in rats resulted in disruption of the tight junctions
that seal the bile canaliculi39. This increased tight junction permeab-
ility might lead to an increase in paracellular permeability and a
regurgitation of bile components back into the plasma. In line with
this hypothesis, we observed a sharp increase in TBA andTBIL levels.
In addition, cholestastic diseases, such as primary biliary cirrhosis
and cholangitis, have been associated with inflammation. In our
study, we measured an elevation in the total white blood cell count
in the knockdown mice, indicative of an inflammatory response.
Interestingly, a recent study of the conditional deletion of b-cate-
nin in the liver also resulted in bile canalicular abnormalities and
intra-hepatic cholestasis40, albeit with a less severe phenotype than
that described here. As mentioned earlier, there was no significant
trend in b-catenin translocation associated with the loss of a-catenin.
Hence, it is intriguing to consider that the effect of a-catenin loss in
our system is independent of its role in cell adhesion. The role of E-
cadherin, which is expressed in the liver, is unclear based on see-
mingly conflicting reports. In monolayer cultures of hepatocytes, E-
cadherinwas shown to be important for themaintenance of extended
networks of bile canaliculi41. In b-catenin conditional liver-specific
knockout mice, no change in tight junction morphology or bile
canaliculi appearance was observed42. In all, the lack of a similar
severe phenotype in these studies strengthens the case that the
well-known role of a-catenin in cell adhesion is not the role critical
for the phenotype observed.
The silencing of a-catenin expression in normal homeostatic liver
incurred a more modest phenotype, with slight alterations in BC
morphology and liver enzymes, but no change in liver mass.
Hence, this shows that a-catenin is especially important during a
time period of rapid proliferation and formation of new structures
during the regenerative period, rather than during a senescent state
of the liver. Indeed, the presence of a-catenin seems to be crucial and
necessary for normal liver regeneration, and its loss appears to affect
the process acutely and persistently. We observed an increase in cell
proliferation and bile canalicular defects in all a-catenin knockdown
livers harvested at various time points. Alpha-catenin knockdown
induced a striking phenotype of a grossly enlarged liver attributed
partially to hepatomegaly and partially to increased proliferation and
severe defects in bile canalicular formation, changes that mimic the
clinical condition of cholestasis. Compared with its known interact-
ing partners, which exhibit relatively modest phenotypes when affec-
ted, a-catenin appears to be important in numerous signalling
pathways connected with normal liver function, liver regeneration
and cholestasis. By understanding the role of a-catenin in these
processes, we can shed light on the associated pathologies and
develop prospective corresponding treatments.
Methods
Injection of siRNA-nanolipids.Animal protocols were approved by the Institutional
Animal Care and Use Committee at A*STAR, Singapore and conformed to National
Institutes of Health guidelines and public law. All experiments were performed in
accordance with these approved animal protocols. siRNA targeting transcripts of
alpha-catenin were synthesized by Axolabs (Kulmbach, Germany). 2’OMe modified
nucleic bases and dTsdT 3’ overhangs (‘s’ indicates phosphorothioate linkage) were
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introduced to increase siRNA in vivo stability, and inhibit immune stimulation.
siRNAs were formulated into lipidoid nanoparticles (LNP) targeting preferentially
the liver, with a particle mean diameter of ,60–80 nm43–46. In order to ensure
significant knockdown of each gene at both mRNA and protein levels, 9- to 11-week-
old Balb/cByJ femalemice were injected via the tail vein with LNP at a dose of 0.5 mg/
kg body weight every 5 days for 20 days, with an additional injection performed at day
27.
Partial hepatectomy. Partial hepatectomy was performed on the animals on day 25,
as previously described4. Dissected lobes were fixed in 10% neutral-buffered formalin
or fresh-frozen on dry ice. Fresh tissue was also frozen-down for protein and RNA
analyses. Seven days after surgery, the mice were sacrificed and the livers were
harvested for analysis.
Cell culture. AML12 cells were purchased from ATCC (Manassas, VA, USA), and
cultured according to ATCC recommended conditions. Transfection was performed
using Lipofectamine 2000 (Life Technologies) with ON-TARGETplus mouse a-
catenin siRNA (Thermo Fisher Scientific),
Hepatocyte isolation, seeding and culturing. Hepatocytes were isolated from male
Wistar rats by a two-step in-situ collagenase perfusion method. Animals were
handled according to the IACUC protocol approved by the IACUC committee of the
National University of Singapore. With a yield of .108 cells/rat, viability of the
hepatocytes was tested to be.90% by Trypan Blue exclusion assay. Freshly isolated
rat hepatocytes (0.2 million) were seeded onto 24-well plate and cultured in 0.5 ml of
William’s E culture medium supplemented with 2 mM L-Glutamine, 1 mg/ml BSA,
0.3 mg/ml of insulin, 100 nM dexamethasone, 50 mg/ml linoleic acid, 100 units/ml
penicillin, and 100 mg/ml streptomycin, all of which were purchased from Aldrich-
Sigma. Cells were incubated with 5% CO2 at 37uC and 95% humidity. After 3-hour
incubation, the unattached cells were removed. Culture medium was changed on a
daily basis. 0.25 mL 0.5 mg/ml neutral collagen was added into each well 24 hours
after cell seeding and incubated at 37uC for 3 hours. Fresh medium was added after
gelation of collagen.
Immunohistochemistry. Tissues fixed in formalin were either embedded in Tissue-
Tek (Sakura Finetek Europe B.V, The Netherlands) or embedded in paraffin and
sectioned accordingly. The fresh-frozen sections were fixed in ethanol at 220uC for
30 min. The paraffin sections were de-paraffinised, rehydrated and subjected to
antigen retrieval using a sodium citrate buffer. They were blocked using 2.5% bovine
serum albumin (Sigma-Aldrich, St. Louis, MO, USA) and 0.3% Triton X-100 (VWR,
Poole, England) for 2 h, after which the sections were incubated with primary
antibody solution overnight at 4uC, followed by incubation with the appropriate
secondary antibody for 1.5 h. The slides were then stained with DAPI and mounted
with Vectashield (Vectorlabs, Burlingame, CA, USA). The antibodies used were
rabbit anti-N-cadherin (ab18203; Abcam, Cambridge, MA, USA), rabbit anti-
collagen IV (ab6586; Abcam), rabbit anti-YAP1 (sc-15407; Santa Cruz, Dallas, TX,
USA), rat ZO-1 (DSHB, Iowa City, IA, USA), rabbit anti-Ki67 (ab15580; Abcam) and
phalloidin-AF488 (A12379; Life Technologies, Carlsbad, CA, USA). Primary
antibodies were detected with AF546-conjugated and AF488-conjugated secondary
antibodies (Life Technologies). Imaging was performed using a fluorescence
microscope (CTR6000; Leica,Wetzlar, Germany) or a confocal microscope (LSM700;
Zeiss, Oberkochen, Germany).
Immunofluorescence and image acquisition. Hepatocytes or AML12 cells were
fixed in 4% paraformaldehyde (PFA) for 30 min, and permeabilized for 30 min in
TBST (0.2% Triton-X in TBS). The permeabilized cells were blocked with 1% BSA in
TBST for 4 h and incubated with phalloidin-Alexa 488 (Life Technologies) for 1 h in
the dark at room temperature. After staining with DAPI (Sigma-Aldrich), cells were
mounted in mounting medium (DAKO, Carpinteria, CA, USA). A 3D stack of
confocal microscopy images were acquired with 1003NA1.4 oil lens on aNikonA1R
Confocal Microscope.
Blood chemical analysis. Blood was collected via cardiac puncture using a 21-G
needle under anaesthesia. A haematology panel (HEMAVET 950FS, Thermo Fisher
Scientific, Waltham, MA, USA) and a blood chemistry panel of serum markers and
enzymes (VETSCAN VS2, Abaxis, Union City, CA, USA) were analysed using
automated methods in the Histopathology Department of the Institute of Molecular
Cell Biology, A*STAR. Total bile acid levels in serum were analysed using a
commercially available kit from Diazyme (Poway, CA, USA), and each sample was
tested in triplicate. Phospholipids, triglycerides, and total cholesterol levels in plasma
were determined using commercially available kits from Biovision (Mountain View,
CA, USA),Wako Chemicals (Richmond, VA, USA), and Stanbio (Boerne, TX, USA),
respectively,
Ki67 and YAP quantification. Each sample was double-labelled with an anti-Ki67
antibody and DAPI, and a total of 20 images were taken at 403 magnification.
Similarly, each sample was labelled with anti-YAP, and images were taken at 203
magnification. The numbers of Ki67-positive or YAP-positive nuclei in each field
were quantified using ImageJ software (NIH, Bethesda, MD, USA). The percentage of
Ki67-positive or YAP-positive nuclei was then calculated by dividing the total
number of Ki67-positive or YAP-positive nuclei by the total number of nuclei.
Statistical tests and quantification.All p-values were calculated using an unpaired t-
test with a two-tailed distribution and assuming unequal variance. For the cell size
quantification and the liver simulation model, cells were labelled with a membrane
marker to visualize the outline of the cells. A rotational kernel was used to enhance the
membrane signal, and the images were converted to binary images. A distance
transform formula was applied and the local maximum was set as the centre of the
cell. Based on this cell centre, Evolving Generalized Voronoi Diagram47,48 method was
applied to segment the cells. Based on the segmentation results, the probability
distribution function was created for each condition. In order to determine if the
increase in liver size was due to an increase in cell size, a numerical simulation was
conducted. A simulation model was created for both control and siRNA-injected
cells, by taking into consideration 1 million cells for each group and generating the
probability density function for each of them.
RNA extraction and first strand cDNA synthesis. RNA was extracted from frozen
mouse livers and monolayer cells using the Qiagen RNeasy mini kit (Qiagen, Venlo,
The Netherlands) according to the manufacturer’s protocol. First-strand cDNA
synthesis was carried out using a Superscript III reverse transcriptase kit (Life
Technologies).
Real-time PCR. Real-time PCR with SYBR green detection or Taqman gene
expression assays was used to confirm knockdown and evaluate the expression levels
of various genes from both cell cultures and tissue samples, performed with the
following primers: E-cadherin F: CAGCCTTCTTTTCGGAAGACT, R: GGTAGA
CAG CTC CCT ATG ACT G. a-catenin F: TCT CTA CTG CCA CCA GCT CAA C,
R: AAG CCA TCC CCT GTG ACT TCT. MRP2 F: GTG TGG ATT CCC TTG GGC
TTT, R: CAC AAC GAA CAC CTG CTT GG MRP3 F: CTG GGT CCC CTG CAT
CTA C, R: GCC GTC TTG AGC CTG GAT AAC MDR1: Quantitect primers
QT01051988, MDR2: Quantitect primers QT00164010 (Qiagen, Venlo, The
Netherlands). CTGF: Mm01192932_g1, ACTIN: Mm00487499 (Life Technologies).
Appropriate non-template controls were included in each run.
Electron microscopy. Liver tissue samples were fixed in a 0.1 M phosphate buffer,
pH 7.4, containing 4% PFA, 2.5% GA, and 0.2% picric acid, and then post-fixed in
0.1 M sodium cacodylate trihydrate, pH 7.6, comprising 1% osmium tetroxide and
1.5% potassium ferricyanide. Samples were then dehydrated, stained with 2% uranyl
acetate in 75% ethanol, infiltrated with acetone and embedded in resin. The blocks
were then trimmed to remove excess resin. An ultramicrotome was used to create 0.5-
mm semi-thin sections, which were stained with methylene blue with Borax. After
identifying the area of interest, each sample was then trimmed down to an area less
than 3 mm.Ultrathin sections of 90-nmwere cut and collected with 150mesh copper
grids. Grids were then stained with heavy metal stains, uranyl acetate (10 min) and
lead citrate (8 min), for contrast. Viewing and image acquisition were performed on
the Jeol 1220 TEM (Tokyo, Japan).
Western blot. Liver tissues were homogenized on ice for 5 sec and then lysed in RIPA
buffer containing 2 mM/ml Na3VO4 and 1x protease inhibitor cocktail (Sigma-
Aldrich) for 20 min at 4uC.Whole tissue lysates were separated using SDS-PAGE and
transferred onto a PVDF membranes. Primary antibodies used were Alpha-catenin
(610194; BD Biosciences, San Jose, CA, USA), GAPDH (ab9485; Abcam), Yap (4912;
Cell Signaling, Danvers, MA, USA) and phosphor-Yap-Ser127 (4911; Cell Signaling).
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